The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer
Journal
Frontiers in Oncology
Journal Volume
9
Date Issued
2019
Author(s)
SDGs
Publisher
Frontiers Media S.A.
Type
journal article
